(Q38000089)

26 August 2017

Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer (English)

1 reference

26 August 2017

5

E A M Gale

1 reference

26 August 2017

A G Renehan

1

1 reference

26 August 2017

H-C Yeh

2

1 reference

26 August 2017

J A Johnson

3

1 reference

26 August 2017

S H Wild

4

1 reference

26 August 2017

H Møller

6

1 reference

26 August 2017

Diabetes and Cancer Research Consortium

7

1 reference

26 August 2017

4 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

55

1 reference

26 August 2017

1619-1632

1 reference

26 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-012-2526-0

26 August 2017

0 references

cites work

Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Long-term effects of insulin glargine on the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Caution needed for country-specific cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Risk factors for colonic and rectal cancer mortality: evidence from 40 years' follow-up in the Whitehall I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Diabetes mellitus, fasting glucose, and risk of cause-specific death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Does pre-existing diabetes affect prostate cancer prognosis? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

The underuse of screening services among elderly women with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Comparison of various characteristics of women who do and do not attend for breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Regional variations in cancer screening rates found in women with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Overweight, obesity, and colorectal cancer screening: disparity between men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Relationship of prostate-specific antigen to age and testosterone in men with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Does diabetes care compete with the provision of women's preventive care services?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Comorbidity as a predictor of stage of illness for patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Diabetes mellitus: a predictor for late radiation morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Colorectal cancer: another complication of diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Quality of diabetes care among cancer survivors with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

Obesity and prostate cancer screening in the USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2526-0

The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

12 December 2020

The delivery of preventive services in primary care practices according to chronic disease status

1 reference

12 December 2020

Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer

1 reference

12 December 2020

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

12 December 2020

Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence

1 reference

12 December 2020

Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study

1 reference

12 December 2020

The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus

1 reference

12 December 2020

Screening mammogram utilization in women with diabetes

1 reference

12 December 2020

The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden

1 reference

12 December 2020

Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study

1 reference

12 December 2020

The influence of other diseases upon the outcome of colorectal cancer patients.

1 reference

12 December 2020

Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes

1 reference

12 December 2020

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

12 December 2020

Impact of diabetes mellitus on outcomes in patients with colon cancer

1 reference

12 December 2020

Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer

1 reference

12 December 2020

Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database

1 reference

12 December 2020

Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics

1 reference

12 December 2020

Reduced screening mammography among women with diabetes

1 reference

12 December 2020

10.1007/S00125-012-2526-0

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference